Adverse Drug Reaction Monitoring and Assessment in Clinical Settings

Abstract

Implementing a structured Adverse Drug Reaction monitoring program is an effective method to proactively identify ADRs, hence enhancing the standard of patient care. The evaluation and monitoring of the safety of medications in clinical use are crucial for mitigating harm to patients and enhancing public health. In a clinical setting, this means establishing a highly structured Pharmacovigilance system. Pharmacovigilance is a crucial practice for monitoring drug-related concerns that arise after a medicine has been marketed and used in real-world settings. Pharmacovigilance and all matters concerning drugs are significant for those whose lives are affected in any kind by medical interventions. Adverse drug reactions (ADRs) significantly affect public health by diminishing patients' quality of life and imposing a substantial financial burden on healthcare systems, particularly during periods of financial crisis. Every healthcare provider has responsibilities in ensuring a harmonious equilibrium between the advantages and drawbacks of a medication. After a drug becomes accessible to the general public, assessing its safety becomes a collective duty of everyone involved in the process of prescribing, which includes patients as well. Healthcare workers play a crucial role in documenting and reporting suspected adverse drug reactions (ADRs).